Secretory phospholipase A
2 (sPLA
2) has been found to be present in both rabbit
12 and human tears.
13 14 15 16 17 Cells in the main and accessory lacrimal glands secrete this enzyme.
14 sPLA
2 cleaves fatty acids from phospholipids at the
sn-2 position. With Gram-positive bacteria, membrane damage is due to the cleavage of fatty acids from phospholipids and the large number of cationic residues on the surface of the enzyme.
18 This enzyme is extremely active against
S. aureus in vitro
19 20 21 and is currently thought to be the most potent antistaphylococcal factor in tears.
17 The anti-staphylococcal activity of sPLA
2 is enhanced in the presence of agents that permeabilize the bacterial cell wall, such as lysostaphin.
22 In addition, sPLA
2 has shown activity against the Gram-negative bacteria
Escherichia coli and
Listeria monocytogenes.
23 The Gram-negative antibacterial activity of sPLA
2 is increased in the presence of bactericidal/permeability-increasing protein.
24 Apart from its antibacterial function, sPLA
2 is proinflammatory and acts on a range of cells. sPLA
2 activates arachidonic acid metabolism and induces cyclooxygenase-2, leading to the release of prostaglandins and leukotrienes.
25 sPLA
2 is also responsible for cytokine production, such as IL-6 and TNF-α.
26 Intolerant contact lens wearers have been found to have elevated concentrations of this enzyme in their tears.
27